Niagen Bioscience, Inc. — Director's Dealing 2014

Jan 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2014-01-21

Reporting Person: Honig Barry C (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-21	Common Stock	A	250000	—	Acquired	4824959	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3390257	Indirect

Footnotes

F1: The restricted shares are awarded to compensate for the efforts on behalf of the Corporation. These shares have certain vesting conditions and shall not vest on or before July 1, 2014.

F2: Indirect ownership includes, after giving effect to all transactions included in this Form 4, (i) 230,000 Shares owned by GRQ Consultants, Inc. Defined Benefits Plan for the benefit of the Reporting Person; (ii) 966,786 Shares owned by GRQ Consultants, Inc. 401K of which the Reporting Person is the beneficiary; (iii) 2,103,571 Shares owned by GRQ Consultants Inc. Roth 401K FBO Renee Honig, the Reporting Person's spouse, of which the Reporting Person has voting and investment power and disclaims beneficial ownership; and (iv) 89,900 shares Shares owned by GRQ Consultants, Inc., of which the Reporting Person is the President.